arginine has been researched along with ACTH-Producing Pituitary Adenoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brito, LP; Bronstein, MD; Fragoso, MC; LerĂ¡rio, AM; Mendonca, BB; Soares, IC | 1 |
Andrioli, M; Bianchi, A; Cavagnini, F; De Marinis, L; De Martin, M; Giampietro, A; Pecori Giraldi, F; Pontecorvi, A; Sacco, E; Scacchi, M | 1 |
2 other study(ies) available for arginine and ACTH-Producing Pituitary Adenoma
Article | Year |
---|---|
Influence of the fibroblast growth factor receptor 4 expression and the G388R functional polymorphism on Cushing's disease outcome.
Topics: ACTH-Secreting Pituitary Adenoma; Adolescent; Adult; Amino Acid Substitution; Arginine; Child; Female; Gene Expression; Glycine; Humans; Hypophysectomy; Male; Middle Aged; Pituitary ACTH Hypersecretion; Pituitary Neoplasms; Polymorphism, Single Nucleotide; Prognosis; Receptor, Fibroblast Growth Factor, Type 4; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
Topics: ACTH-Secreting Pituitary Adenoma; Adult; Aged; Arginine; Cushing Syndrome; Female; Follow-Up Studies; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypopituitarism; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms; Predictive Value of Tests; Remission Induction; Risk Factors; Sex Distribution | 2007 |